长轴视野PET扫描仪在肿瘤患者中动态18F-FDG数据集动力学建模与参数成像的初步结果
本研究对24例肿瘤患者使用长轴视野PET/CT系统进行65分钟动态18F-FDG扫描,从多器官、脑灰白质及血管结构提取时间活度曲线,采用不可逆双组织室模型和Patlak模型拟合,并生成参数图像。结果显示肿瘤病灶中2TC与Patlak法估算的MRFDG无统计学显著差异(配对t检验,P=0.65),直接与间接Patlak法生成的Ki图像肿瘤/本底比值均优于SUV图像(TBRmean平均分别提高3.1倍和3.0倍)。结论证实全身动力学建模与参数成像在基础研究和肿瘤学研究中可行。
要点
- 肿瘤病灶中2TC与Patlak模型估算的MRFDG无统计学显著差异(配对t检验,P=0.65)。
- 直接与间接Patlak法生成的Ki图像TBRmean较SUV图像平均分别提高3.1倍和3.0倍。
- 直接Patlak法生成流入图像的肿瘤病灶对比噪声比是间接Patlak法的两倍。
核心结论
- 使用线性和非线性模型对动态全身18F-FDG图像进行多器官药代动力学建模。
- 参数图像未显示比SUV图像更多的肿瘤,但结果证实参数成像提供了改善的肿瘤对比度。
- 证实了全身动力学建模和参数成像在基础研究和肿瘤学研究中的可行性。
- 长轴视野PET可通过提供高灵敏度参数图像和允许全身药代动力学分析来增强动态成像能力。
研究设计与样本
- 24例肿瘤患者使用长轴视野PET/CT系统进行持续65分钟的动态18F-FDG扫描。
- 从多器官、脑灰质和白质以及血管结构的半自动分割中提取时间活度曲线。
- 使用不可逆双组织室模型和Patlak模型拟合组织和肿瘤病灶的时间活度曲线。
- 使用直接和间接Patlak方法生成参数图像并评估其性能。
主要发现
- 报告了不同器官和肿瘤病灶的动力学参数及葡萄糖代谢率(MRFDG)估计值。
- 部分器官中2TC与Patlak模型估算的MRFDG值之间存在显著差异。
- 肿瘤病灶中2TC与Patlak方法估算的MRFDG值无统计学显著差异(配对t检验,P=0.65)。
- 直接和间接Patlak法生成的净流入(Ki)图像肿瘤/本底比值(TBR)优于标准摄取值(SUV)图像,TBRmean平均分别提高3.1倍和3.0倍。
- 直接Patlak法生成流入图像的肿瘤病灶对比噪声比是间接Patlak法图像的两倍。
关键数值与推荐
- 肿瘤病灶中2TC与Patlak模型估算的MRFDG比较:配对t检验P=0.65,无统计学显著差异。
- 直接Patlak法Ki图像TBRmean较SUV图像平均提高3.1倍。
- 间接Patlak法Ki图像TBRmean较SUV图像平均提高3.0倍。
- 直接Patlak法流入图像肿瘤病灶对比噪声比为间接Patlak法的两倍。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the kinetics of 18F-fluorodeoxyglucose (18F-FDG) by positron emission tomography (PET) in multiple organs and test the feasibility of total-body parametric imaging using an image-derived input function (IDIF). METHODS: Twenty-four oncological patients underwent dynamic 18F-FDG scans lasting 65 min using a long axial FOV (LAFOV) PET/CT system. Time activity curves (TAC) were extracted from semi-automated segmentations of multiple organs, cerebral grey and white matter, and from vascular structures. The tissue and tumor lesion TACs were fitted using an irreversible two-tissue compartment (2TC) and a Patlak model. Parametric images were also generated using direct and indirect Patlak methods and their performances were evaluated. RESULTS: We report estimates of kinetic parameters and metabolic rate of glucose consumption (MRFDG) for different organs and tumor lesions. In some organs, there were significant differences between MRFDG values estimated using 2TC and Patlak models. No statistically significant difference was seen between MRFDG values estimated using 2TC and Patlak methods in tumor lesions (paired t-test, P = 0.65). Parametric imaging showed that net influx (Ki) images generated using direct and indirect Patlak methods had superior tumor-to-background ratio (TBR) to standard uptake value (SUV) images (3.1- and 3.0-fold mean increases in TBRmean, respectively). Influx images generated using the direct Patlak method had twofold higher contrast-to-noise ratio in tumor lesions compared to images generated using the indirect Patlak method. CONCLUSION: We performed pharmacokinetic modelling of multiple organs using linear and non-linear models using dynamic total-body 18F-FDG images. Although parametric images did not reveal more tumors than SUV images, the results confirmed that parametric imaging furnishes improved tumor contrast. We thus demonstrate the feasibility of total-body kinetic modelling and parametric imaging in basic research and oncological studies. LAFOV PET can enhance dynamic imaging capabilities by providing high sensitivity parametric images and allowing total-body pharmacokinetic analysis.
引用
- Sari H, Mingels C, Alberts I, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022. PMID: 34981164. doi:10.1007/s00259-021-05623-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。